STOCK TITAN
  1. Home
  2. Sec-filings
  3. IBIO
  4. [EFFECT] iBio, Inc. SEC Filing

[EFFECT] iBio, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 9, 2026 5:00 P.M.
Form: S-3
CIK: 0001420720
Company Name: iBio, Inc.
File Number: 333-293085

Source: View Original Filing on SEC EDGAR

Stock IBIO logo
Ibio

NASDAQ:IBIO

IBIO Rankings

#5282 Ranked by Market Cap
N/A Ranked by Dividends

IBIO Latest News

Feb 10, 2026
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
Jan 9, 2026
iBio Announces $26 Million Private Placement
Nov 24, 2025
iBio to Participate in the 8th Annual Evercore Healthcare Conference
Nov 12, 2025
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
Oct 30, 2025
iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance

IBIO Latest SEC Filings

Feb 10, 2026
[10-Q] iBio, Inc. Quarterly Earnings Report
Feb 10, 2026
[8-K] iBio, Inc. Reports Material Event
Feb 9, 2026
[424B3] iBio, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 30, 2026
[S-3] iBio, Inc. Shelf Registration Statement
Jan 30, 2026
[Form 4] iBio, Inc. Insider Trading Activity

IBIO Stock Data

73.87M
19.73M
2.86%
16.45%
10.9%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK